Kaneq Bioscience Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Kaneq Bioscience Ltd. - overview
Location
Montreal, QC, Canada
Primary Industry
Biotechnology
About
Kaneq Bioscience Ltd. is a domain name specialist offering sales and leasing services aimed at individuals and businesses seeking to establish a robust online presence. Kaneq Bioscience Ltd. provides services related to internet domain names.
The company was founded by Daniel Bouthillier and is headquartered in Montreal, Canada. Kaneq Bioscience Ltd. has engaged in funding activities, with a notable investment from TVM Capital in January 2013. Kaneq.
com specializes in the sale and leasing of internet domain names, providing a streamlined process for clients looking to establish their online presence. The core offering is the domain name kaneq. com, available for direct purchase at a price of USD 4,888 or through a Lease to Own option costing USD 385 per month. This service caters to a diverse clientele, including startups and established businesses, aiming to secure memorable domain names for branding.
The platform supports secure payment transactions and offers local currency options at checkout, enhancing accessibility for customers across North America, Europe, and Asia. Kaneq. com also focuses on simplifying the domain acquisition process with free transaction support and hassle-free transfers. Kaneq.
com generates revenue primarily through the sale and leasing of domain names, with customers choosing between full purchases or monthly leasing arrangements. The flagship offering, the domain name kaneq. com, is priced at USD 4,888 for outright purchase, while the leasing option provides flexibility for clients preferring a lower initial financial commitment. The revenue model is strengthened by secure payment processing and customer support, ensuring smooth transactions and fostering trust among users.
Kaneq Bioscience Ltd. plans on leveraging recent funding to enhance its domain name offerings and expand into new geographic markets. The company is designing new products aimed at improving user experience and is targeting expansion into Europe and Asia by 2024. Recent financing from TVM Capital in January 2013 is expected to support these initiatives, facilitating the development of innovative services and expanding their reach within the domain name industry.
Current Investors
TVM Capital Life Science
Primary Industry
Biotechnology
Sub Industries
Biotechnology
Website
www.kaneq.com
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Kaneq Bioscience Ltd. - employee data


Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.